Form D · Other Health Care
NuvoMed, Inc.
Seattle, WA · CIK 0001574541
Offering snapshot reported Apr 8, 2015 · SEC filing
- Reported sold
- $391K Offering amount: $1.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $5.17K Reported outside-investor minimum
- First sale
- Jul 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2015 | Initial | $390,637 | No comparison | 12 | SEC filing |
| Jan 22, 2014 | Amendment | $535,016 | $50,000vs Apr 18, 2013 | 14 | SEC filing |
| Apr 18, 2013 | Initial | $485,016 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237549
Source: Form D, filed Apr 8, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Burton Bentley, Ii | Director |
| Rick Gibson | Director |
| Shelly Lanning | Director |
| Kent T. Smith | Director |
| Ashley S. Williams | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2300 E. Roy Street
Seattle, WA, 98112
Seattle, WA, 98112